MARKET

PSTV

PSTV

Plus Therapeutics Inc
NASDAQ
0.7201
+0.0221
+3.17%
Opening 12:11 05/14 EDT
OPEN
0.7060
PREV CLOSE
0.6980
HIGH
0.7446
LOW
0.6806
VOLUME
2.94M
TURNOVER
--
52 WEEK HIGH
2.670
52 WEEK LOW
0.2400
MARKET CAP
12.24M
P/E (TTM)
-0.3685
1D
5D
1M
3M
1Y
5Y
1D
Verve Therapeutics (VERV) Reports Q1 Loss, Tops Revenue Estimates
NASDAQ · 3h ago
Plus Therapeutics announces presentation of new data on REYOBIQ
TipRanks · 4h ago
PLUS THERAPEUTICS’ REYOBIQ™ SHOWS CLINICAL BENEFIT AND SAFETY IN THE RESPECT-LM CLINICAL TRIAL FOR PATIENTS WITH LEPTOMENINGEAL METASTASES (LM)
Reuters · 4h ago
Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Misses Revenue Estimates
NASDAQ · 1d ago
Weekly Report: what happened at PSTV last week (0505-0509)?
Weekly Report · 2d ago
Plus Therapeutics Inc <PSTV.OQ> expected to post a loss of 15 cents a share - Earnings Preview
Reuters · 4d ago
This Block Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Benzinga · 05/05 12:11
Plus Therapeutics Cut to Hold From Buy by D. Boral Capital
Dow Jones · 05/05 11:35
More
About PSTV
More
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is engaged in developing targeted radiotherapeutics for difficult-to-treat cancers of the central nervous system. Combining image-guided local beta radiation and targeted drug delivery approaches, it is advancing a pipeline of product candidates with lead programs in leptomeningeal metastases (LM) and recurrent glioblastoma (GBM). Its lead radiotherapeutic candidate, REYOBIQ (rhenium (186Re) obisbemeda), is designed specifically for CNS cancers including GBM, LM, and pediatric brain cancers (PBC) by direct localized delivery utilizing approved standard-of-care tissue access such as with convection-enhanced delivery (CED) and intraventricular brain (Ommaya reservoir) catheters. Its radiotherapeutic candidate, Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere (188RNL-BAM), is designed to treat many solid organ cancers including primary and secondary liver cancers via intra-arterial injections.
Recently
Symbol
Price
%Change
    OPI
  • 0.2551
  • -5.20%

Webull offers Plus Therapeutics Inc (USA) stock information, including NASDAQ: PSTV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PSTV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PSTV stock methods without spending real money on the virtual paper trading platform.